Endo International
ENDPQ
#10594
Rank
C$0.19 M
Marketcap
C$0.0008289
Share price
0.00%
Change (1 day)
-94.09%
Change (1 year)

Revenue for Endo International (ENDPQ)

Revenue in 2023 (TTM): C$2.69 Billion

According to Endo International 's latest financial reports the company's current revenue (TTM ) is C$2.77 Billion. a decrease over the revenue in the year 2022 that were of C$3.14 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Endo International from 2001 to 2023

Annual revenue

Year Revenue Change
2023 C$2.66 B-15.21%
2022 C$3.14 B-17.51%
2021 C$3.81 B3.05%
2020 C$3.70 B-2.75%
2019 C$3.80 B-5.19%
2018 C$4.01 B-7.95%
2017 C$4.36 B-19.07%
2016 C$5.38 B18.85%
2015 C$4.53 B55.19%
2014 C$2.92 B11.63%
2013 C$2.61 B-13.05%
2012 C$3.01 B8.4%
2011 C$2.77 B61.88%
2010 C$1.71 B11.61%
2009 C$1.53 B0.29%
2008 C$1.53 B41.52%
2007 C$1.08 B2.26%
2006 C$1.05 B10.92%
2005 C$0.95 B29.25%
2004 C$0.73 B-4.38%
2003 C$0.77 B22.61%
2002 C$0.63 B56.98%
2001 C$0.40 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Cara Therapeutics
CARA
C$9.85 M-99.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Zogenix
ZGNX
C$0.11 B-95.94%๐Ÿ‡บ๐Ÿ‡ธ USA